RxDoctor Payments Data

Christine Yono

Family · Bloomfield Hills, MINPI 1649945825

Payments from drug & device makers

$3,021in general payments, 2019–2025

Across 120 payments — averaging $25.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$366
  • Novo Nordisk$336
  • AbbVie$284
  • GSK$276
  • Pfizer$248
  • Lilly USA, LLC$243
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,021100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,021 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide17$16,847
OzempicSemaglutide14$14,510
JardianceEmpagliflozin13$11,106
SynthroidLevothyroxine Sodium19$1,965
Omeprazole54$1,044
Rosuvastatin Calcium76$725
Levothyroxine Sodium30$511
Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril15$407
Atorvastatin Calcium32$387
Gabapentin22$286
Albuterol Sulfate HfaAlbuterol Sulfate11$265
Clonazepam33$260
Lorazepam20$223
Losartan Potassium20$213
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$243$16,84717 claims
Novo NordiskOzempic$336$14,51014 claims
Boehringer IngelheimJardiance$66$11,10613 claims
AbbVieSynthroid$284$1,96519 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$40$51130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,657 family providers in Michigan.

Other family in Bloomfield Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →